SAGIMET BIOSC.CL.A -,0001

SAGIMET BIOSC.CL.A -,0001

Share · US7867001049 · SGMT · A3CPAM (XNMS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of SAGIMET BIOSC.CL.A -,0001
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
5
1
0
0
No Price
29.04.2026 08:47
Current Prices from SAGIMET BIOSC.CL.A -,0001
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
SGMT
USD
29.04.2026 08:47
8,67 USD
-0,08 USD
-0,91 %
XDQU: Quotrix
Quotrix
SBIRSC49.DUSD
EUR
29.04.2026 05:27
7,50 EUR
-0,10 EUR
-1,32 %
IEXG: IEX
IEX
SGMT
USD
28.04.2026 19:59
8,76 USD
0,56 USD
+6,77 %
XDUS: Düsseldorf
Düsseldorf
SBIRSC49.DUSB
EUR
28.04.2026 17:30
7,22 EUR
0,18 EUR
+2,56 %
ESG Risk Rating
B Good
Share Float & Liquidity
Free Float 84,66 %
Shares Float 27,11 M
Shares Outstanding 32,02 M
Company Profile for SAGIMET BIOSC.CL.A -,0001 Share
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

Company Data

Name SAGIMET BIOSC.CL.A -,0001
Company Sagimet Biosciences Inc.
Symbol SGMT
Website https://sagimet.com
Primary Exchange XNMS Frankfurt
WKN A3CPAM
ISIN US7867001049
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO David A. Happel
Market Capitalization 280 Mio
Country United States of America
Currency EUR
Employees 0,0 T
Address 155 Bovet Road, 94402 San Mateo
IPO Date 2023-07-17

Ticker Symbols

Name Symbol
Düsseldorf SBIRSC49.DUSB
Frankfurt 0O2.F
NASDAQ SGMT
Quotrix SBIRSC49.DUSD
More Shares
Investors who hold SAGIMET BIOSC.CL.A -,0001 also have the following shares in their portfolio:
ADVANCED INFO S.-FGN-BA 1
ADVANCED INFO S.-FGN-BA 1 Share
CREDIT AGRI. 20/31 MTN
CREDIT AGRI. 20/31 MTN Bond